Targets
The panel covers relevant targets for the following major myeloid disorders:
-
Acute Myeloid Leukemia (AML)
-
Myeloid Dysplastic Syndrome (MDS)
-
Chronic Myeloid Leukemia (CML)
-
Chronic Myelomonocytic Leukemia (CMML)
-
Juvenile Myelomonocytic Leukemia (JMML)
Myeloid
Panel
Our Myeloid Panel enables concurrent analysis of both DNA and RNA from blood and bone marrow samples in a single assay to study the biomarkers associated with hematologic malignancies.
This panel targets biomarkers across 69 genes including challenging targets such as CEBPA and FLT3-ITDs. With our expertise and accuracy level, our laboratory is able to detect somatic mutations down to 5% frequency.
FULL GENE LIST :
ABL1, ALK, ASXL1, BCL2, BCOR, BRAF, CALR, CBL, CCND1, CEBPA, CREBBP, CSF3R, DNMT3A, EGFR, ETV6, EZH2, FGFR1, FGFR2, FLT3, FUS, GATA2, HMGA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KMT2A, KRAS, MECOM, MET, MLLT10, MLLT3, MPL, MYBL1, MYD88, MYH11, NF1, NPM1, NRAS, NTRK3, NUP214, PDGFRA, PDGFRB, PHF6, PRPF8, PTPN11, RARA, RB1, RBM15, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, STAG2, TCF3, TET2, TFE3, TP53, U2AF1, WT1, ZRSR2
We have you covered...
With our extensive billing coverage we are able to provide a broad range of patients access to this panel. We accept all major insurances, PPOs, HMOs, Medicare, and Medi-Cal